Forte Biosciences (FBRX) Enterprise Value (2016 - 2020)
Historic Enterprise Value for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to -$20.2 million.
- Forte Biosciences' Enterprise Value rose 2103.21% to -$20.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$20.2 million, marking a year-over-year increase of 2103.21%. This contributed to the annual value of -$6.9 million for FY2019, which is 8299.81% up from last year.
- Latest data reveals that Forte Biosciences reported Enterprise Value of -$20.2 million as of Q3 2020, which was up 2103.21% from -$27.7 million recorded in Q2 2020.
- Forte Biosciences' Enterprise Value's 5-year high stood at -$4.1 million during Q3 2016, with a 5-year trough of -$76.1 million in Q2 2017.
- Over the past 5 years, Forte Biosciences' median Enterprise Value value was -$20.2 million (recorded in 2020), while the average stood at -$24.5 million.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 173077.3% in 2017, then soared by 8299.81% in 2019.
- Quarter analysis of 5 years shows Forte Biosciences' Enterprise Value stood at -$5.5 million in 2016, then plummeted by 552.14% to -$35.9 million in 2017, then decreased by 13.58% to -$40.8 million in 2018, then soared by 83.0% to -$6.9 million in 2019, then plummeted by 191.11% to -$20.2 million in 2020.
- Its Enterprise Value stands at -$20.2 million for Q3 2020, versus -$27.7 million for Q2 2020 and -$14.2 million for Q1 2020.